Taiwanese Drug Manufacturers—Specialty & Generic Industry Analysis

Benchmark and data visualization of Taiwanese public listed companies in the Drug Manufacturers—Specialty & Generic Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.

Taiwan public listed companies in the Drug Manufacturers—Specialty & Generic industry: 29

Taiwan Drug Manufacturers—Specialty & Generic total companies market cap (USD): $12.79 Billion

Top 10 Taiwanese Drug Manufacturers—Specialty & Generic Industry Companies Details as of July 1, 2024

Company	Market Cap (USD)	Country	Sector	Industry
Lotus Pharmaceutical Co. Ltd	$2.47 B	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
Bora Pharmaceuticals Co. Ltd	$2.24 B (Jan. 1, 2024)	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
Center Laboratories, Inc.	$1.21 B	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
Grape King Bio Ltd	$698.4 M	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
ScinoPharm Taiwan Ltd	$691.0 M	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
TTY Biopharm Company Ltd	$586.5 M	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
Alar Pharmaceuticals, Inc.	$517.3 M	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
Synmosa Biopharma Corp	$480.5 M	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
Handa Pharmaceuticals, Inc.	$455.0 M	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic
YungShin Global Holding Corp	$427.9 M	Taiwan	Healthcare	Drug Manufacturers—Specialty & Generic